Evidence map›Paper›PMID 27677782›Full record

ArticleCurrent topics in behavioral neurosciences2017

MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.

Eugene A Kiyatkin, Suelynn E Ren

Open access · hybridAbstract read
In one paragraph

Article in Current topics in behavioral neurosciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eugene A KiyatkinBehavioral Neuroscience Branch, National Institute on Drug Abuse - Intramural Research Program, NIH, 333 Cassell Drive, Baltimore, MD, 21224, USA. ekiyatki@intra.nida.nih.gov.
Suelynn E RenBehavioral Neuroscience Branch, National Institute on Drug Abuse - Intramural Research Program, NIH, 333 Cassell Drive, Baltimore, MD, 21224, USA.
National Institute on Drug Abuse · US

Funding

Brain Temperature, Reward, And Drugs Of AbuseZIADA000445 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI KIYATKIN, EUGENE A · 2009 to 2020
$4.1M
Brain Temperature, Reward, And Drugs Of AbuseZ01DA000445 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI KIYATKIN, EUGENE A · 2001 to 2008
$1.8M
IMPROVING EFFICACY OF DRUG ABUSE TREATMENTK24DA000445 · NIDA · YALE UNIVERSITY · PI SCHOTTENFELD, RICHARD S · 2000 to 2009
$1.3M
Intramural NIH HHS Z01 DA000445NIDA NIH HHS K24 DA000445
6 · The paper itself

Abstract

Psychomotor stimulants are frequently used by humans to intensify the subjective experience of different types of social interactions. Since psychomotor stimulants enhance metabolism and increase body temperatures, their use under conditions of physiological activation and in warm humid environments could result in pathological hyperthermia, a life-threatening symptom of acute drug intoxication. Here, we will describe the brain hyperthermic effects of MDMA, MDPV, and methylone, three structurally related recreational drugs commonly used by young adults during raves and other forms of social gatherings. After a short introduction on brain temperature and basic mechanisms underlying its physiological fluctuations, we will consider how MDMA, MDPV, and methylone affect brain and body temperatures in awake freely moving rats. Here, we will discuss the role of drug-induced heat production in the brain due to metabolic brain activation and diminished heat dissipation due to peripheral vasoconstriction as two primary contributors to the hyperthermic effects of these drugs. Then, we will consider how the hyperthermic effects of these drugs are modulated under conditions that model human drug use (social interaction and warm ambient temperature). Since social interaction results in brain and body heat production, coupled with skin vasoconstriction that impairs heat loss to the external environment, these physiological changes interact with drug-induced changes in heat production and loss, resulting in distinct changes in the hyperthermic effects of each tested drug. Finally, we present our recent data, in which we compared the efficacy of different pharmacological strategies for reversing MDMA-induced hyperthermia in both the brain and body. Specifically, we demonstrate increased efficacy of the centrally acting atypical neuroleptic compound clozapine over the peripherally acting vasodilator drug, carvedilol. These data could be important for understanding the potential dangers of MDMA in humans and the development of pharmacological tools to alleviate drug-induced hyperthermia - potentially saving the lives of highly intoxicated individuals.

Indexed as

AnimalsAntipsychotic AgentsBenzodioxolesBody TemperatureBrainCarbazolesCarvedilolCentral Nervous System StimulantsClozapineEnvironmentFeverHumansInterpersonal RelationsMethamphetamineN-Methyl-3,4-methylenedioxyamphetaminePropanolaminesAntipsychotic AgentsBenzodioxolesCarbazolesCarvedilolCentral Nervous System StimulantsClozapineMethamphetaminemethyloneN-Methyl-3,4-methylenedioxyamphetaminePropanolaminesPyrrolidinesSynthetic CathinoneVasodilator AgentsActive ingredients of “bath salts”Brain metabolismCerebral heat productionDrug-induced intoxicationDrugs of abuseMDMA (Ecstasy)Psychomotor stimulantsRave partiesVasoconstriction

Identifiers

PMID27677782
PMCPMC6112168
OpenAlexW2527563110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.